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Fetuin-A is a major constituent of the fetal bovine serum used extensively in cell culture media. We hereby present data demonstrating
that breast carcinoma cells can adhere to immobilized fetuin-A in a calcium-dependent fashion. Interestingly, the cells can also divide and
attain confluency under these conditions. Using a proteomic approach, we have identified annexin-II and -VI as the putative cell surface
receptors for fetuin-A in the presence of Ca2+ ions. Biotinylation of cell surface proteins followed by immunoprecipitation revealed that
annexin-VI was expressed on the extracytoplasmic surface of the cell membranes. Finally, to demonstrate that annexin-II and -VI were the
adhesive receptors for fetuin-A, siRNA knockdown of expression of the annexins significantly reduced the calcium-mediated adhesion.
Interestingly, we demonstrated that the tumor cells could also adhere to immobilized fetuin-A in the presence of magnesium ions, and that
this adhesion was most likely mediated by integrins because neutralizing antibodies against h1 integrins substantially reduced the adhesion.
Our studies suggest that the expression of annexin-II and -VI and possibly other members of the family mediate novel adhesion and signaling
mechanisms in tumor cells.
D 2004 Elsevier B.V. All rights reserved.Keywords: Fetuin-A; Annexin-II; Annexin-VI; Adhesion; MDA-MB-231; Calcium1. Introduction
Fetuin-A is a serum glycoprotein initially identified in
fetal and newborn calf serum and subsequently detected in
sheep, pig, goat, mice, rat and humans [1]. During
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doi:10.1016/j.bbamcr.2004.06.005
Abbreviations: ECIS, electric cell-substrate impedance sensing; FDA,
fluoresceine diacetate; MALDI-TOF, matrix assisted laser desorption
ionization-time of flight; FRET, fluorescence resonance energy transfer;
PAGE, polyacrylamide gel electrophoresis
* Corresponding author. Department of Biochemistry, Meharry Med-
ical College, Nashville, TN 37208. Tel.: +1 615 327 6119; fax: +1 615 327
6442.
E-mail address: jochieng@mmc.edu (J. Ochieng).increases to approximately 3 mg/ml and rapidly decreases
after birth to a level of ~0.6 mg/ml in the adult human
plasma. Fetuin-A can be detected in allantoic, amniotic [2]
as well as the cerebrospinal fluids [3]. It is a member of the
cystatin superfamily [4] and is produced and secreted into
the blood by the liver [5]. It has been linked to several
physiological functions ranging from brain development [6]
to bone remodeling and immune function [7,8]. Probably its
most important function in normal physiology is its ability
to prevent ectopic calcification [9].
Fetuin-A has long been known to support the attachment
and growth of a variety of cell types in culture [2]. It is the
major constituent of fetal bovine serum, the preferred
growth supplement in most tissue culture media [2,10,11].
However, its role in adhesion and growth of cells in cultureta 1693 (2004) 111–123
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suggested that its biological properties are mediated by the
growth and adhesion factors which co-purify with it in the
serum [2]. We and others have reported the presence of
fetuin-A binding sites on tumor cells [12,13]. In the present
study, we demonstrate, using a proteomic approach, the
presence of annexin-II and -VI in the plasma membranes of
the breast carcinoma cell line MDA-MB-231. Of all the cell
surface proteins in these cells, the annexins have a
preferential binding interaction with immobilized fetuin-A
in a calcium-dependent manner.
Annexins belongs to a ubiquitous multigenic superfamily
of water-soluble, calcium-dependent membrane aggregating
proteins that share certain properties and are related by the
amino acid sequence [14]. They are present in both plant
and animal cells and there are about 13 members in the
family identified so far [15,16]. Annexins, like fetuins, have
also been implicated in various biological processes.
Extracellular molecules like tenascin C, plasminogen and
tissue plasminogen activator (t-PA) have been demonstrated
to be ligands for annexin-II [17]. Annexin-VI is a unique
protein in this family both structurally and functionally.
While other annexins contain four copies of the dannexin
repeatsT, annexin-VI has eight, possibly as a result of gene
duplication [18]. Annexin-VI has a widespread tissue
distribution [19] and plays a role in cell growth regulation,
intracellular homeostasis and secretory pathways [18,20–
22]. It has also been demonstrated to be differentially
expressed in murine melanoma cell lines [21]. Despite their
initial identification as intracellular proteins because of their
lack of signal peptides, annexins can be transported to the
extracellular environment where they are likely to play key
physiological roles. Annexin-II and -VI are expressed on
murine RAW 117 large-cell lymphoma cells where they
serve as surface receptors for tumor cell-endothelial cell
interaction [23,24]. Annexin-VI is also expressed on the
surface of several human and rodent tumor cell lines [25].
We hereby report that annexin-II and -VI are the putative
receptors for fetuin-A on the surface of tumor cells and that
the receptor–ligand interaction has a requirement for
calcium ions and intact fetuin-A with its full complement
of sialic acid residues.2. Materials and methods
Fetuin-A (F3004, processed by gel filtration) and
asialofetuin (types I and II) were purchased from Sigma.
Asialofetuin types II and III were prepared by enzymatic
cleavage using neuraminidase. Rabbit polyclonal antibodies
to annexin-II and -VI were from Biodesign (Saco, ME). The
immunogens were HPLC-purified synthetic peptides corre-
sponding to residues 9–30 of the N-terminus of annexin-II
monomer and residues 1–16 of the N-terminus of annexin-
VI. Annexin-II and -VI siRNA and their corresponding
scrambled siRNA were purchased from Qiagen (Valencia,CA). All the other reagents unless otherwise stated were
purchased from Sigma.
The breast tumor cell lines MCF-10A, MDA-MB-231
and MDA-MB-435 were purchased from ATCC and are
routinely maintained in DMEM medium supplemented with
10% heat inactivated fetal bovine serum, 2 mM glutamine,
100 Ag/ml streptomycin, 100 IU/ml penicillin. The DMEM/
F12 medium (Sigma; cat # D-9785) used in this study does
not contain Ca2+ and Mg2+ ions. When supplemented with
10% fetal bovine serum, all the divalent ions are derived
from the serum. Concentrations of Ca2+ and Mg2+ ions in
the serum-free medium were adjusted accordingly.
2.1. Cell adhesion assay
The cells were grown in DMEM with 10% FBS. They
were detached with 2 mM EDTA and washed three times
with sterile physiological buffer (150 mM NaCl, 10 mM
HEPES, pH 7.4) and the number of cells/ml determined
using a hemocytometer. Sterile 96-well cell culture plates
were either coated with fetuin-A (0–5 mg/ml) or collagen-
IV (0–5 mg/ml). The nonspecific sites in these wells were
blocked with 3% BSA. Cells resuspended in physiological
buffer at a concentration of 4104 cells/well were added to
the coated plates in the presence or absence of the respective
ions (Ca2+, Mg2+). The plates ware incubated at 37 8C for
90 min. The nonadherent cells were then washed off and to
the adhered cells, fluoresceine diacetate (FDA) in DMSO
was added to a final concentration of 20 AM in 100 Al of the
physiological buffer. The fluorescence at 520 nm following
excitation at 485 nm (slits—5 nm), emitted from the cells
(arbitrary units of fluorescence) was determined by a
luminescence spectrophotometer LS 55 (Perkin Elmer) with
a fluorescence plate reader attachment, and was proportional
to the number of cells per well.
2.2. Analysis of adhesion of breast carcinoma cells to
fetuin-A and collagen IV in the absence and presence of
function-blocking antibodies against b1 integrins
In an effort to determine whether the Mg2+-dependent
adhesion of the breast carcinoma cells to fetuin-A was
mediated by integrins, we repeated the adhesion studies in
the absence and presence of function-blocking anti-integrins
antibodies. We made use of MDA-MB-435 cells which have
been shown to use a1h1 integrins to adhere to collagen IV
[26] (positive control). The wells of 96-well microtiter
plates were coated with the optimal concentration of either
fetuin-A or collagen IVas determined above. To these wells,
4104 cells were added in the presence of either 2 mM
Mg2+ or 2 mM Ca2+ and in the presence of either
nonimmune IgG or mouse anti h1 integrins (MAB1965)
(Chemicon, Temecula, CA) at a concentration of 5 Ag/100
Al. The cells were allowed to adhere for 2 h, after which the
nonadherent cells were washed off and the number of
adhered cells determined as above.
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Having determined that the breast cancer cells could
adhere to immobilized fetuin-A in a calcium-dependent
manner, we next questioned whether this adhesion also
involved cell spreading. We therefore analyzed the adhesion
by ECIS, an instrument designed to measure the degree of
cell spreading. MDA-MB-231 cells in DMEM/F12 (lacking
calcium and magnesium ions) were counted and resus-
pended. The ECIS plates were coated with bovine fetuin-A
for 2 h and blocked with 3% BSA for 30 min. Electrodes
were washed with appropriate media and 200 Al of the
media was added to each well and the basal resistance and
impedance was measured. Cells (4105 cells/well) in
DMEM/F12 with or without Ca2+ ions were added to the
wells in a total volume of 400 Al/well. The attachment and
spreading was then measured using ECIS [27]. Cell motions
on the scale of nanometers are manifested as fluctuations in
the impedance of small gold film electrodes that serve as
cell substrata by itself or in conjunction with another
adhesion molecule (fetuin-A).
2.4. Identification of cell surface receptors for fetuin-A
Plasma membranes were obtained from MDA-MB-231
cells by subcellular fractionation using a sucrose gradient as
described [28]. The membrane fraction was aliquoted into
two equal fractions and incubated with Affigel 15(BioRad)
agarose beads linked to bovine fetuin without and with 2
mM Ca2+ for 3 h at 37 8C. The fetuin-agarose linked
proteins were pelleted down at 10,000g for 3 min and the
beads were washed extensively with physiological buffer in
the absence and presence of 2 mM Ca2+. The pellets were
eluted with 2 mM EDTA and the proteins denatured with
sample loading buffer and resolved on a precast 12% SDS-
PAGE (Invitrogen), and stained with silver stain (Sigma).
2.5. Matrix assisted laser desorption/ionization-time of
flight (MALDI-TOF)
The protein bands were excised from the silver-stained
1D SDS-PAGE gel on a light box and control bands were
excised for each band. They were then cubed and
equilibrated in 100 mM NH4HCO3. Reduction and alkyla-
tion was carried out with DTT (3 mM in 100 mM
NH4HCO3, 37 8C for 15 min) and iodoacetamide (6 mM
in 100 mM NH4HCO3 for 15 min). The gel slices were then
destained and dehydrated with 50% acetonitrile in 50 mM
NH4HCO3, followed by 100% acetonitrile. Gel slices were
rehydrated with 15-Al 25 mM NH4HCO3 containing 0.01
Ag/Al modified trypsin and trypsin digestion was carried out
for 2 h at 37 8C. Peptides were extracted with 60%
acetonitrile, 0.1% trifluoroacetic acid, dried by vacuum
centrifugation, and reconstituted in 10-Al 0.1% trifluoro-
acetic acid. Peptides were then desalted and concentrated
into 2-Al 60% acetonitrile, 0.1% trifluoroacetic acid usingZipTipC18 pipette tips. Of the sample, 0.4 Al was applied to
a target plate and overlaid with 0.4-Al alpha-cyano-4-
hydroxycinnamic acid matrix (10 mg/ml in 60% acetoni-
trile, 0.1% trifluoroacetic acid). MALDI-TOF mass spec-
trometry was carried out using a Voyager 4700 mass
spectrometer (Applied Biosystems) operated in reflectron
mode. The mass spectrum was calibrated to within 20 ppm
using trypsin autolytic peptides present in the sample (m/
z=842.50, 1045.56 and 2211.09 Da). Ions ([M+H]) corre-
sponding to peptide masses were used to interrogate the
SWISS PROT and NCBInr databases using the MASCOT
(http://www.matrixscience.com) and ProFound (http://
prowl.rockefeller.edu) algorithms, respectively.
2.6. Fluorescence resonance energy transfer (FRET)
analysis of the binding of fetuin-A with annexin-VI
Having determined by MALDI-TOF that annexin-II and
-VI are the prominent cell surface proteins which
interacted with fetuin-A, purified annexin-VI was pur-
chased from Chemicon and its interaction with fetuin-A in
solution analyzed by FRET. FRET allows the quantitative
determination of noncovalent molecular associations at
Angstrom levels. It is a process by which radiationless
transfer of energy occurs from a fluorophore of donor to
an acceptor molecule in close proximity [29]. The
tryptophan residue of annexin-VI was used as the donor
and the Dans moiety in the Dans-labeled fetuin-A as the
acceptor. Fetuin-A was labeled using Dansyl chloride as
previously described [30]. The stoichiometry of labeling
was calculated by determining absorbance at 280 and 350
nm. Fluorescence excitation at 350 nm and emission at
450 nm were determined for Dans-fetuin-A.
Fetuin Awas added to 5 nM solution of annexin-VI in 40
mM HEPES, 0.15 mM NaCl, pH 7.5 and 1 mM DTT
without and with 2 mM CaCl2, or 2 mM MgCl2, or 10 mM
EDTA at a final concentration of 0–30 nM. FRET was
determined by Luminescent Spectrometer LS 55(Perkin
Elmer) by the measurement of decreasing fluorescence at
344 nm (slit 10 nm) following excitation at 296 nm (slit 4
nm). The difference between the experimental (fetuin-
A+annexin-VI) and control (without annexin-VI) was
determined and the binding constant (Kb) calculated using
the Chipman method [31], using the equation dF/
C=aKb*dF, where dF is the decreasing fluorescence at
344 nm and C is the concentration of fetuin-A added.
2.7. Expression of annexin-VI on the surfaces of MDA-MB-
231 cells
To further analyze the interaction between annexins on
MDA-MB-231 cells and fetuin-A, the plasma membrane
fractions were incubated with fetuin-A-affigel beads in the
absence and presence of 2 mM Ca2+ ions. The bound
proteins were resolved in a precast 12% SDS-PAGE,
transferred to immobilon membranes and incubated with
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MDA-MB-231 cells were also surface biotinylated using
NHS-Biotin according to manufacturer’s protocol (BioRad).
The cells were subsequently lysed and the lysate pre-cleared
with protein-A agarose. The lysate was then divided into
two equal parts. One part was incubated with nonimmune
rabbit IgG, and the other part with the rabbit polyclonal
antibody against annexin-VI overnight at 4 8C followed by
immunoprecipitation using protein-A agarose. The pulled
down proteins were resolved in 12% SDS-PAGE, trans-
ferred to immobilon membranes and the blot probed with
avidin-HRP and developed as described above.
2.8. Knocking down the expression of annexin-II and -VI by
siRNAs
To confirm that annexin-II and -VI were the cell surface
receptors for fetuin-A, we decided to knockdown their
expression in the MDA-MB-231 cells using the siRNA
approach. The cells were seeded in 24-well microtiter plates
at 8104 cells/well and grown in the DMEM/F12 culture
medium without phenol red. The siRNAs were designed to
target the following sequences: annexin-II, 5V-AAGGTA-
CAAGAGCTACAGCCC-3V and for annexin-VI, 5V-
AAGATGCCATCTCGGGCATTG-3V. At approximately
70% confluence, 1 ng of the appropriate siRNA as well as
scrambled siRNA (transfection controls) were added to 100
Al of the culture medium (without phenol red). To this, 6 Al
of RNAiFect (Qiagen) transfection reagent was added and
mixed thoroughly by vortexing (10 s). After a brief
incubation for 10–15 min at 25 8C, the transfection complex
was added to the wells containing the cells and incubated for
40 h (annexin-II) and 60 h (annexin-VI). At the end of the
incubations, the cells were detached, cell number deter-
mined and divided into two portions. One portion was used
for adhesion assays and the other for Western blot analysis
to determine the extent of knockdown. The wells of a 96-
well microtiter plate were coated with 2.5 mg/ml of fetuin-
A, blocked with 3% BSA, and 2104 cells added to theFig. 1. Adhesion of MDA-MB-231 cells to collagen IV, fetuin-A, and
asiolofetuins. The wells of a 96-well microtiter plate were coated with
serially diluted doses of either collagen IV (Panel A) or fetuin-A (Panel B) in
PBS overnight at 4 8C. The MDA-MB-231 cells in serumless medium were
then added to the wells at 4104 cells/well in the presence of either Mg2+ or
Ca2+ ions. After 2 h of incubation at 37 8C, the nonadherent cells were
washed off in serumless medium containing the respective divalent ions.
FDAwas added to the adherent cells at a final concentration of 20 AM. After
5 min of incubation at room temperature, fluorescence emission from the
wells was determined by a fluorescence plate reader and reported as arbitrary
units of fluorescence. In Panel C, the wells of a 96-well microtiter plate were
coated with BSA, fetuin-A and three different batches of asialofetuin at ~500
Ag/ml. The coating was done overnight at 4 8C, after which nonspecific sites
were blocked with 2% BSA at 37 8C for 15 min. Cells (MDA-MB-231 and
MCF-10A) were added to the wells (4104 cells/well) in serumless medium
containing 2 mM Ca2+ ions. After 2 h of incubation, the nonadherent cells
were washed off and DAF added to the attached cells and fluorescence (auf)
determined as above. (For color see online version).wells (quadruplicates/treatment) in the presence of 2 mM
Ca2+. After 2 h of incubation, FAD was added to the
adherent cells and cell number determined as above or the
adhered cells were fixed in 5% glutaraldehyde in PBS for 30
min, followed by staining with 0.1% (w/v) crystal violet in
96-well microtiter plates. The stain was released from the
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plate reader (Dynex). The optical density was proportional
to the number of cells in the wells. The other portion of the
cells was lysed, protein concentration determined and 40 Ag
per protein sample analyzed by Western blot using a rabbit
polyclonal antibody to annexin-II monomer and annexin-VI
expression.
2.9. Cell proliferation assay
MDA-MB-231 cells were allowed to adhere to fetuin-A-
coated wells (500 Ag/well) at 2104 cell/well in serum-free
medium without (control) or with 2 mM Ca2+ in quad-
ruplicates and incubated at 37 8C in humidified CO2
incubator for 3 days. The cells were also allowed to grow
in complete medium as a positive control. Every 24 h, the
number of viable cells per well was determined by the
Alamar blue assay [32]. In this assay reducing conditions,
mitochondrial activity turns the Alamar blue dye from blue
to pink with increased fluorescence at 590 nm after
excitation at 544 nm. The dye (200 Al) was added to the
wells at a dilution of 1:20 and initial fluorescence taken
using a luminescence spectrophotometer LS 55 (Perkin
Elmer) with a fluorescence plate reader attachment. The
plate was allowed to incubate at 37 8C for 1 h, after which
another reading was taken. This process was repeated three
times and the average of the increase in fluorescence per
hour in arbitrary units of fluorescence (auf) was determined.Fig. 2. Adhesion and spreading of MDA-MB-231 cells on fetuin-A. Adhesion and
were coated with fetuin-A at 1 mg/ml, followed by blocking of nonspecific sites by
(SF), 2 mM Ca2+ (SF+Ca), or 2 mM EDTA (SF+EDTA). Spreading was observe
represent adhesion and spreading in the first 30 min. The cells (4104 cells/wel
described in Fig. 1 in the absence (Panel C) or presence (Panel D) of 2 mM Ca2+
adherent cells fixed in 5% glutaraldehyde, stained with crystal violet and photog3. Results
3.1. Adhesion of the breast carcinoma cells to fetuin-A and
collagen IV
The MDA-MB-231 and other breast carcinoma cells
generally adhere well to collagen, laminin, fibronectin and
vitronectin in the presence of divalent ions such as
magnesium or manganese but not calcium. In such
instances, the cells use integrins as the principal cell
surface receptors to interact with the matrix adhesion
proteins [33] (Fig. 1A). Apart from the major extracellular
matrix proteins mentioned above, fetuin-A has also been
shown to promote cellular adhesion. However, the cell
surface receptors, which mediate cell/fetuin-A interaction,
as well as the mechanism of interaction have not been
elucidated to date. We hereby demonstrate that MDA-MB-
231 and other breast carcinoma cells adhere rapidly to
wells coated with fetuin-A in the presence of magnesium
or calcium ions (Fig. 1B). Whereas the adhesion in the
presence of magnesium is likely to be mediated by
integrins, the adhesion in the presence of calcium ions
only, we argued, was due to a novel receptor(s) on the
surface of tumor cells. This adhesive interaction was rapid,
taking place within the first 2 h of plating. The optimal
concentration of fetuin-A at which adhesion occurred was
approximately 500 Ag/well. Interestingly, the calcium-
mediated adhesion of cells to fetuin-A required sialic acidspreading of cells to fetuin-A was determined using ECIS. The electrodes
2% BSA. Cells were resuspended in serum-free medium containing nothing
d as increased resistance. The inset in Panel A was blown up in Panel B to
l) were also allowed to adhere to microtiter plates coated with fetuin-A as
ions. The nonadherent cells were washed off after 2 h of incubation and the
raphed. (For color see online version).
Table 1
Adhesion of MDA-MB-435 cells to fetuin-A and collagen IV in the
presence of either Mg2+ or Ca2+ ions and in the absence and presence of
function-blocking anti h1 integrin antibodies (% of control)
Substratum Nonimmune mouse
IgG (control)
Mouse anti h1
integrin (IgG)
Fetuin-A(Mg2+) 100 80.5F0.6*
Fetuin-A (Ca2+) 100 95.0F5
Collagen-IV (Mg2+) 100 63.5F12.5*
* Significant reduction in adhesion compared to control ( Pb0.05).
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fetuin-A, because asialofetuin (ASF) did not support
adhesion (Fig. 1C). Three batches of asialofetuin-A were
used and cells could not adhere to any of them. Apart from
MDA-MB-231, other aggressive breast carcinoma cell
lines including MDA-MB-435 adhered rapidly to fetuin-
A in the presence of Ca2+ ions (data not shown). Normal
breast epithelial cells including the spontaneously immor-
talized MCF-10A, on the other hand, failed to adhere to
fetuin-A in the presence of Ca2+ ions within the first 2 h
(Fig. 1C). The same was true for less aggressive breast
tumor cell lines such as BT-549 (data not shown).
The cells did not just adhere to fetuin-A, they also spread
efficiently in this substratum, showing early signs of
spreading within 20 min post-plating (Fig. 2, panels A
and B). Adhesion and spreading was not observed in the  
Fig. 3. Identification of cell surface proteins that bind to fetuin-A. The MDA-M
subcellular fractionation. Purified plasma membrane fractions were incubated with
Ca2+ ions. After incubation, the beads were washed extensively in the respective
resolved on a 12% SDS-PAGE. A purified membrane fraction (lane A) was also an
affigel beads in the presence of Ca2+ ions, were cut from the gel and subjected to M
identified as annexin-II with a predicted molecular weight of 38.8 kDa. The M
(N1.65=95% confidence). The total coverage was 57%. MALDI-TOF of the ~70 k
molecular weight of 76.2 kDa. The MOWSE score was 125 (N73=95% confidence
47%. (For color see online version).absence of Ca2+ ions (Fig. 2, panels A, B and C). The
spreading pattern (Fig. 2, panel D) was similar to that
observed when the cells adhered to collagen or fibronectin
in the presence of Mg2+/Mn2+ ions (Fig. 1A).
3.2. Function-blocking antibodies against b1 integrins
abrogate cellular adhesion to fetuin-A in the presence of
Mg2+ but not in the presence of Ca2+ ions
In an effort to distinguish the Mg2+- from Ca2+ ion-
mediated adhesion of breast carcinoma cells to fetuin-A, we
hypothesized that Mg2+ was involved in integrin-dependent
adhesion while Ca2+ ions mediated a novel adhesion
mechanism. We demonstrated that the adhesion of the
MDA-MB-435 cells to fetuin-A in the presence of Mg2+
ions could be inhibited significantly by function-blocking
anti-b1 integrins when compared to control cells in the
presence of nonimmune mouse IgG (Table 1). As expected,
the antibodies did not significantly alter the adhesion of the
cells to fetuin-A in the presence of Ca2+ ions. The adhesion
of the cells to collagen -IV was also reduced by anti-b1
integrins because these cells use mainly a1b1 integrins to
adhere to collagen IV. The data therefore suggest that the
adhesion of breast carcinoma cells to fetuin-A in the
presence of Mg2+, and even Mn2+ (data not shown),
involves b1 integrins and possibly other integrin hetero-
dimers, such as a5b1, with specificity for fibronectins whichB-231 cells were lysed and the plasma membrane fraction obtained by
fetuin-A-affigel beads in the absence (lane B) or presence (lane C) of 2 mM
buffers (without and with Ca2+ ions). The bound proteins were eluted and
alyzed as control. Two unique protein bands, which were bound to fetuin-A-
ALDI-TOF. The ~40-kDa (Band 1) band from the silver stain was positively
OWSE score was 247 (N73=95% confidence) and the Z score was 2.27
Da (Band 2) band was positively identified as annexin-VI with a predicted
) and the Z score was 2.32 (N1.65=95% confidence). The total coverage was
Fig. 4. Proof of the interaction between cell surface annexin-VI and fetuin-
A. The MDA-MB-231 plasma membrane fraction was incubated with
fetuin-A-affigel beads without (Panel A, lane 1) and with (Panel A, lane 2)
2 mM Ca2+ ions. After washing off the beads in the respective buffers, the
bound proteins were dissolved in sample buffer, resolved on SDS-PAGE
and analyzed by Western blot using antibodies to annexin-VI and visualized
by enhanced chemiluminescence reagents. To demonstrate the presence of
annexin-VI on the extracytoplasmic surface of the plasma membranes,
biotinylated cells were washed, lysed and the lysates incubated with
nonimmune rabbit IgG (Panel B, lane 1) or polyclonal rabbit antibodies
against annexin-VI (Panel B, lane 2). These were then subjected to
immunoprecipitation using protein-A agarose, resolved on SDS-PAGE
followed by Western blot and probed with avidin-HRP.
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adhesion, on the other hand, is novel and does not involve
integrins which normally require either Mg2+ or Mn2+ for
proper adhesion.
3.3. Cell surface receptors for Ca2+-mediated adhesion of
MDA-MB-231 to fetuin-A
Using a proteomic approach, we next sought to identify
the Ca2+-dependent cell surface receptors for fetuin-A. The
plasma membrane fraction of MDA-MB-231 was incubated
with fetuin-A agarose beads in the absence and presence of
calcium ions. The bound proteins were eluted after extensive
washing in the respective buffers and resolved on SDS-
PAGE and protein bands visualized by silver stain. In three
separate experiments, two bands with approximate molec-
ular weights of 75 and 35 kDa were observed in Fig. 3, lane
C, where the membrane proteins were incubated with fetuin-
A agarose in the presence of Ca2+ ions. The bands were not
observed when the membrane proteins were allowed to
interact with immobilized fetuin-A in the absence of Ca2+
ions (Fig. 3, lane B). All the membrane proteins are depicted
in Fig. 3, lane A. These bands were excised and subjected to
MALDI-TOF analysis. Protein band # 1 with the approx-
imate molecular weight of 35 kDa was identified as annexin-
II with a confidence level approaching 100%. Two inde-
pendent statistical analyses were performed to determine the
confidence level. The MOWSE score was 247 (N73=95%
confidence) and the Z score was 2.27 (N1.65=95% con-
fidence). The coverage map showed a 57% total coverage of
the protein. Band #2, on the other hand, was identified as
annexin-VI. The molecular weight was confirmed as being
76.2 kDa. Again two independent statistical analyses were
performed to determine the confidence level. The MOWSE
score was 125 (N73=95% confidence) and the Z score was
2.32 (N1.65=95% confidence). The coverage map showed a
47% total coverage of the protein. An interesting observation
was that there were a few peptides matching long-chain fatty
acid CoA ligase. The statistical analysis determined that it
was not significant and the coverage was also poor. Although
long-chain fatty acid CoA ligase has been demonstrated on
the plasma membrane of adipocytes in mammals [34], there
are no data to suggest that it is present on the cell surface of
tumor cells.
3.4. Cell surface expression of annexin-VI
MALDI-TOF data strongly suggested that both annexin-
II and -VI interact with fetuin-A. To further investigate this
interaction, plasma membrane protein fractions were
obtained from MDA-MB-231 cells as described above and
incubated with fetuin-agarose beads in the absence and
presence of 2 mM Ca2+ (Fig. 4A) for 3 h at 37 8C. After
isolating the proteins that bound to fetuin-A and resolving
them on SDS-PAGE gel, they were transferred onto
immobilon membrane and probed with the polyclonalantibody to annexin-VI. This was then visualized using
chemiluminescence. The plasma membrane fraction which
was incubated with 2 mM calcium had a strong signal at 75
kDa (annexin-VI) (Fig. 4A, lane 2), as expected. A faint
band at the same molecular weight (Fig. 4A, lane 1) was
also evident, meaning that annexin-VI was bound to fetuin-
A in the absence of Ca2+ albeit with a lower affinity.
Annexin-VI is a membrane protein which has not only
been observed on the extracytoplasmic surface of the
membrane, but also in intracellular vesicles engaged in
endocytosis [35]. However, for the protein to be considered
an ideal surface receptor for an extracellular protein such as
fetuin-A, at least part of the molecule should be localized
on the extracytoplasmic surface. Therefore, to determine
that location of the annexin-VI motif which interacts with
fetuin-A, cell surface proteins of MDA-MB-231 were
biotinylated with NHS-Biotin (BioRad). The cells were
lysed and the labeled proteins analyzed by immunopreci-
pitation using the polyclonal antibody to annexin-VI or
nonimmune rabbit IgG. This was followed by a Western
blot analysis with avidin-HRP to visualize the biotinylated
cell surface proteins that were pulled down with anti-
annexin-VI antibodies. A strong signal was observed only
M.N. Kundranda et al. / Biochimica et Biophysica Acta 1693 (2004) 111–123118in the lane where the proteins were immunoprecipitated
with anti-annexin-VI antibodies (Fig. 4B, lane 2), demon-
strating that at least part of the annexin-VI protein was on
the extracytoplasmic surface of the plasma membrane of
MDA-MB-231 cells.
3.5. Analysis of the binding interaction between fetuin-A
and purified annexin-VI by FRET
We next analyzed the binding interaction between
purified fetuin-A and annexin-VI. FRET allows the quanti-
tative determination of noncovalent molecular associations
at Angstrom levels. It is a process by which radiationless
transfer of energy occurs from a fluorophore of donor to an
acceptor molecule in close proximity [29]. The two
tryptophan residues of annexin-VI were excited at 296 nm
and emitted fluorescence at 344 nm. This emission (donor)
at 344 nm was used to excite the Dans group (acceptor) of
labeled fetuin-A (Fig. 5A). The binding data were then used
to calculate the binding constants between fetuin-A and
annexin-VI under different conditions. The binding constant
of 68.8 AM1 (Kd=14.5 nM) in the presence of 2 mM Ca2+Fig. 5. Direct interaction between purified annexin-VI and Dans-labeled fetuin-A. T
The energy transfer was from the Trp residues in annexin-VI to the Dans-group
emission at 344 nm. The interaction was monitored without (w/o), with 2 mM
determined by the Chipman approach [31] from the plots of dF/C versus dF.was higher than in the absence of divalent ions, where Kb
was 41.2 AM1 (Kd=24.3 nM) (Fig. 5B). There was,
however, substantial binding interaction between the two
proteins in solution in the absence and presence of divalent
ions (Fig. 5B). This is in contrast to the interactions between
cell surface annexin-VI and immobilized fetuin-A where
calcium ions were required and cellular adhesion and
spreading inhibited in the presence of EDTA (Fig. 2). This
particular finding is not surprising because the cell micro-
environment surrounding the tumor cells is likely to
influence the binding interaction [36,37]. Moreover, cellular
adhesive interactions with matrix proteins are usually not
particularly strong because rapid adhesion and detachment
are necessary for proper cell growth [38].
3.6. Knockdown of annexin-II and -VI expression and
calcium-mediated adhesion of MDA-MB-231 cells to
fetuin-A
To demonstrate that annexin-II and -VI were the bona
fide receptors which mediate the adhesion of the tumor cells
to fetuin-A, the cells were transiently transfected with eitherhe binding interaction between the two proteins was investigated by FRET.
of the labeled fetuin-A, and was determined as decreases in fluorescence
Ca2+, 2 mM Mg2+, and with 10 mM EDTA. The binding constants were
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stranded oligos as controls. The phenotypic manifestation of
knocking down the expression of either annexin-II or VI
was evident as early as 35 h after transfection. During the
knockdown of both annexin-II and -VI, there was gradual
detachment of cells from the culture flasks, underscoring the
importance of the annexins in cellular adhesion. The
reduced adhesion of siRNA transfected cells to fetuin-A
was apparent. In three separate experiments, knocking down
the expression of annexin-II resulted in approximately 30%
reduction in cellular adhesion to fetuin-A in the presence of
calcium (Fig. 6A, bar B), relative to untreated or cells
transfected with scrambled oligos (Fig. 6A, bars A and C,
respectively). The annexin-II protein, on the other hand, was
reduced in the cells by almost 98% (Fig. 6B, lane 2) relative
to untreated and cells transfected with scrambled oligos
(Fig. 6B, lanes 1 and 3, respectively). As for annexin-VI, the
siRNA knockdown resulted in almost 50% reduction in
cellular adhesion to fetuin-A in the presence of Ca2+ ionsFig. 6. Knockdown of annexin-II expression and calcium-mediated
adhesion of MDA-MB-231 cells to fetuin-A. The cells were seeded in
24-well microtiter plates at 8104 cells/well and grown in DMEM/F12
culture medium without phenol red. At approximately 70% confluence, 1
ng of siRNA targeted to annexin-II sequence as well as scrambled siRNA
(transfection controls) were added to 100 Al of culture medium. To this, 6 Al
of the transfection reagent was added and mixed by vortexing. After a brief
incubation at 25 8C, the transfection complex was added to the wells and
incubated for 40 h. The cells were detached, cell number determined and
divided into two parts. One part was used for adhesion assays and the other
for Western blot assays to determine the extent of the knockdown.
Adhesion assays in the presence of Ca2+ ions were done as described in
Fig. 1 (quadruplicates/treatment). Adhesion of control untreated cells (bar
A); cells transfected with annexin-II siRNA (bar B) and cells transfected
with scrambled siRNA (bar C) are represented in Panel A. The annexin-II
expression in control untreated cells (lane 1); cells transfected with annexin-
II siRNA (lane 2); and cells transfected with scrambled siRNA (lane 3) are
depicted in Panels B. The blot in Panel B was stripped and re-probed for h-
actin to show equal loading (Panel C).
Fig. 7. Knockdown of annexin-VI expression and calcium-mediated
adhesion of MDA-MB-231 cells to fetuin-A. The impact of knocking
down the expression of annexin-VI on the adhesion of the cells to fetuin-A
in a calcium-dependent manner was done as described in Fig. 6 with only a
few modifications. The adhesion assay was done by fixing the cells in 5%
glutaraldehyde and staining them with crystal violet. The stain was released
into the wells by adding 100 Al of 10% acetic acid and measuring optical
density at 570 nm by plate reader. Adhesion of control untreated cells (bar
A), cells transfected with scrambled siRNA (bar B), and cells transfected
with annexin-VI siRNA (bar C) are represented in Panel A. The annexin-II
expression in control untreated cells (lane 1), cells transfected with
scrambled siRNA (lane 2), and cells transfected with annexin-VI siRNA
(lane 3) are depicted in Panels B. The blot in Panel B was stripped and re-
probed for h-actin to show equal loading (Panel C).(Fig. 7A, bar C) compared to control untreated cells and
those transfected with scrambled oligos (Fig. 7A, bars A and
B, respectively). Protein expression was reduced by almost
70% by the siRNA (Fig. 7B, lane 3) relative to the control
cells (Fig. 7B, lanes 1 and 2).
3.7. Growth of MDA-MB-231 cells is mediated by fetuin-A
and Ca2+ ions in vitro
Having demonstrated that annexin-II and -VI can
mediate the adhesion of the breast carcinoma cells to
fetuin-A, we finally questioned whether this interaction was
sufficient to transmit growth signals to these cells. The cells
were therefore allowed to adhere to culture plates in
serumless medium containing Ca2+ ions only (Ca); Ca2+
ions and 0.25% w/v of fetuin-A (CF); and complete medium
containing 10% fetal bovine serum (CM) and allowed to
grow at 37 8C for 3 days. The increase in cell number was
Fig. 8. Proliferation of MDA-MB-231 cells in the presence of fetuin-A and
Ca2+ ions. The cells (2104 cells/well) were plated in 96-well culture plates
(quadruplicates/time point) in complete medium (CM), serumless medium
containing Ca2+ (Ca) or serumless medium containing 2 mM Ca2+ ions, and
added to wells coated with fetuin-A (500 Ag/well) (CF). At 24-, 48-, and
72-h time points, Alamar blue was added to the wells corresponding to each
time point and the rate of change of Alamar fluorescence (auf/h) used as a
determinant of cell density and was measured by the luminescence
spectrophotometer LS 55 (Perkin Elmer) with a plate reader attachment.
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surprisingly evident that within 72 h, when these cells are
normally in their log phase of growth, the rate of growth in
serumless medium containing fetuin-A and calcium ions
was the same as the rate for the cells growing in complete
medium (Fig. 8). The rate of growth in the presence of
calcium ions only was low as expected and there was no
exponential increase in cell number. Interestingly, the cells
were also able to grow to the same extent in suspension in
the presence of either fetuin-A/Ca2+ or complete medium
(data not shown). Interestingly, cells in suspension in
eppendorf tubes also responded to fetuin-A/Ca2+ by grow-
ing exponentially (data not shown), meaning that fetuin-A
can rescue these cells from anoikis [39].4. Discussion
It has been our experience that breast carcinoma and
other aggressive tumor cells such as Lewis lung carcinoma
(data not shown) have the ability to adhere and spread on
immobilized fetuin-A in any appropriate physiological
buffer or serumless medium, with a requirement for Ca2+
ions. This observation suggested to us the existence of a cell
surface receptor(s) for the glycoprotein other than integrins,
which normally require manganese or magnesium ions [33].
In the present work, we present evidence that annexin-II and
-VI are the putative tumor cell surface receptors for fetuin-A
adhesion in the presence of Ca2+ ions. This is an important
discovery because despite the fact that fetuin-A has been
known to be a cell attachment factor in fetal bovine serum
since the late 1950s [40], its cell surface receptor(s) has been
elusive. More importantly, since that initial demonstration of
its cell adhesive properties, there has been a serious debate
among cell biologists concerning the mechanism of thisadhesion [2]. One school of thought maintains that the
proteins which co-purify with fetuin-A in vivo are respon-
sible for this adhesion, while the other is a proponent of
fetuin-A per se being the principal adhesion factor [2].
In the present work, we demonstrate a cell/fetuin-A
interaction which requires intact sialic acid residues of the
glycoprotein and Ca2+ ions. Therefore, wherever intact
fetuin-A is immobilized, such as in the various extracellular
matrices in vivo including the bones, one can expect
responsive cells to adhere to or associate with such sites.
Commercial tissue culture dishes can easily be coated with
fetuin-A in the media, and the responsive cells in turn
specifically adhere to the fetuin-A in a calcium ion-
dependent manner. It should, however, be noted that the
bulk of fetuin-A in vivo is soluble and only those fetuin-A
molecules that are immobilized on the substrata participate
directly in cellular adhesion. For example, we have
observed that fetuin-A can easily be immobilized on elastin
fibers, an interaction which may aid the adhesion of tumor
cells to elastin-rich tissues such as the lungs (unpublished
information). The expression of both annexin-II and -VI was
not only deemed necessary for adhesion of tumor cells to
fetuin-A; they also stimulated cell spreading as shown by
siRNA studies, pointing to their potential roles as classical
cell surface receptors for extracellular matrix interaction
[38]. Such interactions normally do not require tight binding
interaction because cellular adhesion, particularly of tumor
cells, is a dynamic process involving rapid adhesion and
detachment [41,42]. However, when the binding interaction
between fetuin-A and annexin-VI was analyzed in solution,
a much tighter binding affinity (in the nanomolar range) was
demonstrated. Binding was not only evident in the presence
of 2 mM Ca2+ as expected; there was some binding in the
absence of Ca2+ ions and even in the presence of 10 mM
EDTA. The requirement of Ca2+ ions for cell adhesion to
fetuin-A suggests that the disposition of annexins on the cell
surface depends on calcium ions [17].
Fetuin-A has been shown to interact with a number of
cellular proteins [2,12,30,43], and we initially hypothesized
that it could bind to several cell surface proteins. The
present data suggest that annexin-II and -VI, and most
likely other members of the annexin family which are
expressed on the cell surface, assume lectin properties with
preference for the sialic acid residues on tri-antennary sugar
moieties found in fetuin-A [44]. The approximate 50%
reduction in adhesion of MDA-MB-231 cells to fetuin-A, as
a result of annexin-VI knockdown, suggests that the
elimination of all other relevant annexins on the surface
would totally abrogate the Ca2+-mediated adhesion of the
cells to fetuin-A.
Both annexin-II and -VI are known to be expressed on
the extracellular membrane surfaces of a number of cells,
despite their lack of signal peptides and obvious membrane
spanning domains [17]. Moreover, the mechanisms by
which they are secreted are likely to be tightly regulated
because only a small proportion, ~4% of the total annexin-
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anisms which control the secretion and cell surface
disposition of the annexins are obviously important deter-
minants in their roles as receptors for extracellular fetuin-A.
Tumor cells which secrete significant quantities of annexins
to the extracellular milieu are more likely, based on the
current data, to adhere rapidly to fetuin-A-coated surfaces.
The scenario may be more complex in vivo because stromal
cells can also secrete annexins which can then bind to the
surfaces of tumor cells resulting in increased adhesion to
fetuin-A.
In the present work, we have demonstrated that the rapid
cell surface annexin/fetuin-A interaction is predominantly a
feature of breast carcinoma cells, particularly the aggressive
ones such as MDA-MB-231. The interaction is weak in less
aggressive breast carcinoma cells such as BT-549 [46] and
normal breast epithelial cells, including MCF-10, which
failed to adhere to fetuin-A even after 3 h of incubation
(data not shown). Increased expression of annexin-II has
been observed in large cell lymphoma and colon adeno-
carcinoma. Annexin-II and -VI have been demonstrated to
be involved in the adhesive interactions between RAW 117
large cell lymphoma and endothelial cells [24,23]. Of note is
the number of studies that have suggested that annexins are
multifunctional cell surface receptors that interact with a
variety of extracellular ligands such as plasminogen and
tissue plasminogen activator [45], tenascin C [47], heparin
[48], and chondroitin sulfate chains [49]. A number of
annexins including annexin-II contain the Cardin–Wein-
traub consensus sequence for glycosaminoglycan recogni-
tion [48]. However, it is unlikely that this is the motif in
annexin-II or -VI which interacts with fetuin-A because
heparin or chondroitin sulfate was unable to abrogate the
adhesion of cells to immobilized fetuin-A (data not shown).
Lastly, the present work suggests that the interaction
between the breast carcinoma cells and fetuin-Avia annexin-
II and -VI sends doutside inT signals into the cells, resulting in
cell spreading and growth. The breast carcinoma cells
attained confluence in the presence of fetuin-A and calcium
ions alone (ruling out the involvement of integrins in this
anchorage-dependent growth signaling). Thus, other than the
stimulation of cellular attachment, the calcium-mediated cell
to fetuin-A interaction could be a key mechanism adapted for
growth stimulation or for rescuing the tumor cells from
apoptosis due to anoikis [39]. Apart from the in vitro cell
culture conditions, we recently demonstrated that fetuin-A
can significantly affect adhesion and growth of tumor cells in
vivo. In a two-stage skin initiation/promotion protocol of
carcinogenesis, skin papillomas were developed in fetuin-A
wild-type and null mice. After 6 weeks of promotion with
phorbol esters, tumor volume in the wild type was
significantly larger than in the fetuin-A null C57/BL-6 mice
(unpublished information), indicating that fetuin-A was
required for growth and expansion of the transformed cells.
The signaling mechanisms by which annexin-II and -VI
promote the growth of tumor cells are currently not known.Annexins, particularly annexin-VI, can form membrane
channels for calcium ion transport from the extracellular
milieu to the cytoplasm [50]. Interestingly, we have
demonstrated that fetuin-A is capable of transiently increas-
ing [Ca2+] in 11-9-1-4 but not in MDA-MB-435 breast
carcinoma cells [46]. Therefore, the interaction of some
tumor cells with fetuin-A in the presence of calcium may
result in increases in intracellular calcium ions, triggering a
variety of signaling mechanisms culminating in cell growth.
Studies reported by Kohn and Liotta [51] have recently
pointed to the importance of extracellular calcium ions as
one of the modulators of tumor progression/metastasis
pathways in vivo.
In as much as we have presented evidence here that cells,
particularly tumor cells, are likely to use the novel fetuin-A/
annexin signaling for adhesion and growth, we have also
demonstrated that other protein/protein interactions are
involved in this cell adhesion/growth-promoting phenom-
enon of fetuin-A. For example, we postulate that the Mg2+
ion-dependent adhesion of breast carcinoma cells to
immobilized fetuin-A is mediated by activated integrins
such as the VLA1 family members, which interact with their
ligands such as fibronectin that associates and co-purifies
with fetuin-A in serum [2]. Another possibility is that fetuin-
A in vivo acts as a bspongeQ or reservoir, attracting and
concentrating a number of unrelated adhesion and growth
factors in the vicinity of tumor cells. We have demonstrated
that fetuin-A interacts with matrix metalloproteinases and,
together with other members of the cystatin family, protects
these enzymes from premature autolytic degradation or
inactivation [30]. It is likely that association of matrix
metalloproteinases with fetuin-A serves an unknown phys-
iological function which is essential for growth.
In summary, we have demonstrated that breast carcinoma
cells can use annexin-II and -VI to interact with fetuin-A.
The cells adhere and spread on immobilized fetuin-A in a
calcium-dependent fashion, making the annexins behave
like C-type lectins or siglecs with a preference for the sialic
acid residues on fetuin-A. We propose that annexin-II and -
VI/fetuin-A signaling is a key tumor cell adhesion/growth
pathway, and the elucidation of the mechanisms involved is
our primary goal.Acknowledgements
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